Bioject Could Fold In June Without Additional Financing
This article was originally published in The Gray Sheet
Executive Summary
Needle-free drug-delivery systems manufacturer Bioject announced April 7 that it may not be able to continue operations past May 31, despite its best efforts to stay afloat